Study at a glance
What is the difference between free and total vitamin D?
For the usual vitamin D status marker, total includes vitamin D attached to blood proteins and the small amount circulating unattached. Free measures only that unattached portion.
Is free vitamin D the same as active vitamin D?
No. Free and total describe whether a vitamin D form is attached to a carrier protein. Active vitamin D is a different form made through further processing in the body.
Why can free and total vitamin D give different pictures?
Changes in carrier proteins can alter the balance between attached and unattached vitamin D. Pregnancy and some liver conditions are examples. Calculations and laboratory methods can also affect the apparent difference.
Is a free vitamin D test better for everyone?
The evidence does not show that. Free and total measurements often move together, and total remains the usual status test. Neither directly measures vitamin D activity in every tissue.
Read the full article below ↓Free and total vitamin D are not competing versions of the same laboratory result. They describe different parts of a circulating transport system whose behaviour depends on vitamin D-binding protein, albumin, tissue uptake, physiological state and analytical method. Across the human evidence, the central finding is therefore conditional rather than binary: total 25-hydroxyvitamin D remains a broadly useful marker of circulating vitamin D status, while free 25(OH)D is a distinct physiological measurement that can become especially informative when the binding environment changes. Understanding why requires connecting the biology of protein binding with the evidence on how free and total vitamin D are actually measured and interpreted.
Vitamin D circulates as a protein-bound system
Most circulating 25(OH)D is not free in plasma. The large majority is bound to vitamin D-binding protein, or DBP, a smaller fraction is bound more weakly to albumin, and only a very small fraction circulates unbound. Total 25(OH)D measures all of these compartments together. Free 25(OH)D measures only the unbound fraction.
This means that the total concentration partly reflects the amount of vitamin D present and partly reflects the transport environment in which that vitamin D is circulating. DBP creates a large, relatively stable circulating reservoir. Albumin provides an additional lower-affinity bound compartment. The free fraction is much smaller and is influenced by the equilibrium among those compartments.
The basic carrier biology is developed in Vitamin D Binding Protein Explained, while Vitamin D Transport Proteins places DBP and albumin within the wider transport and tissue-delivery system.
Why total and free concentrations are related but not interchangeable
Because the free fraction is drawn from the same circulating pool measured by total 25(OH)D, free and total concentrations often move together. That relationship is seen in ordinary populations and during vitamin D supplementation. It would therefore be incorrect to treat total and free 25(OH)D as unrelated biomarkers.
They are nevertheless not interchangeable. If DBP or albumin concentration changes, the distribution of 25(OH)D among bound and unbound compartments can change. The same total concentration can therefore coexist with a somewhat different free concentration, while a change in total 25(OH)D need not be reproduced proportionally in the free fraction.
This is the physiological foundation of the distinction explained more simply in Free vs Total Vitamin D Explained. The important point is not that one number is genuine and the other misleading. Each number describes a different feature of the same transport system.
Rare loss of DBP provides a powerful causal test
Rare human DBP deficiency provides an unusually strong natural experiment because it changes the carrier itself rather than merely comparing people with modest differences in vitamin D status. Henderson and colleagues described a person with homozygous deletion of the GC gene, which encodes DBP. Circulating total vitamin D metabolites were extraordinarily low, yet directly measured free 25(OH)D and calcium-parathyroid physiology were much less severely disturbed than the total concentration alone might have suggested.
This case demonstrates that DBP has a major causal influence on the measured total circulating pool. Remove the principal carrier and total vitamin D metabolites can become extremely low even when some physiological functions remain comparatively preserved.
The boundary is equally important. Complete DBP deficiency is exceptionally rare. It does not establish that ordinary people with very low total 25(OH)D have adequate vitamin D physiology, and it cannot be used to dismiss conventional deficiency states. The case isolates the role of the carrier; it does not erase the biological importance of vitamin D availability.
The free-hormone idea is useful but incomplete for vitamin D
The existence of a free fraction invites comparison with the classical free-hormone hypothesis, in which unbound hormone is regarded as the fraction most readily able to cross cell membranes. For vitamin D metabolites, that model captures part of the physiology but not all of it.
Some tissues can retrieve DBP-bound vitamin D metabolites through receptor-mediated mechanisms involving megalin and cubilin. Protein binding therefore does not create an absolute barrier between bound substrate and cellular access. Different tissues can handle circulating vitamin D in different ways, and the fraction measured as free in blood is not equivalent to a direct measurement of intracellular vitamin D action.
This is why neither free nor total 25(OH)D should be equated automatically with tissue response. What Vitamin D Levels Represent examines this broader distinction between a circulating measurement and the biological processes occurring downstream.
Ordinary populations often show strong agreement between free and total 25(OH)D
The strongest argument against routinely replacing total 25(OH)D with free 25(OH)D comes from the fact that, in many ordinary populations, the two measures correlate strongly. Nielson and colleagues studied 1,057 men drawn from populations in the United States, United Kingdom and The Gambia. Directly measured free 25(OH)D tracked total 25(OH)D closely despite substantial attention to DBP genotype, ancestry and measurement method.
Sollid and colleagues provided complementary evidence in 472 participants from a vitamin D supplementation study. DBP phenotype influenced concentrations and the relationship between total and free measurements, but supplementation generally increased total and directly measured free 25(OH)D in parallel. DBP itself remained comparatively stable.
These findings matter because physiological distinctness alone does not establish clinical superiority. A free fraction can be real, measurable and mechanistically interesting while adding little independent information in many people whose binding-protein physiology is ordinary.
Altered binding states are where the relationship becomes more informative
The relationship becomes less predictable when DBP or albumin changes substantially. Pregnancy and cirrhosis illustrate opposite kinds of altered binding environment. Pregnancy can increase DBP, while cirrhosis can reduce liver-derived proteins including DBP and albumin.
Schwartz and colleagues compared directly measured and calculated free 25(OH)D in clinical populations that included pregnancy and cirrhosis. The work showed that changes in carrier concentration can alter the mapping between total and free concentrations and can also expose weaknesses in calculated estimates.
A later multicohort analysis extended this picture across a broader range of people and clinical states. Total and free 25(OH)D remained related overall, but health condition, DBP, albumin, body composition and other characteristics could modify the relationship.
The real-world implications of these states are treated separately in Why Free and Total Vitamin D Can Diverge Between People. Their importance here is that they connect transport biology directly to measurement interpretation: when the carrier environment changes, the meaning of a total concentration can change with it.
Directly measured free vitamin D and calculated free vitamin D are different analytical objects
Free 25(OH)D can be measured directly or estimated mathematically. These approaches should not be treated as interchangeable.
A calculated free concentration is derived from measured total 25(OH)D, albumin, DBP and assumed binding constants. Every one of those inputs becomes part of the result. Error or bias in DBP measurement can therefore propagate into the calculated free value, and the calculation also depends on assumptions about binding behaviour that may not hold identically across every physiological state.
Direct measurement avoids that particular chain of calculation, but it creates its own analytical challenges because free 25(OH)D exists at very low concentrations. Direct immunoassays and emerging mass-spectrometric approaches therefore require their own validation, harmonisation and reference procedures.
The wider problem of analytical variation is explored in Variability in Vitamin D Measurements and Limitations of Vitamin D Blood Tests.
DBP assay method can alter the apparent biological story
One of the most important lessons from the evidence is that an apparent population difference can originate partly from measurement architecture rather than physiology alone. Earlier work using a monoclonal DBP immunoassay suggested large ancestry-associated differences in DBP concentration and contributed to claims about calculated bioavailable vitamin D.
Nielson and colleagues tested DBP using different analytical approaches, including monoclonal, polyclonal and proteomic methods. The magnitude of the apparent group difference depended strongly on the assay. Directly measured free 25(OH)D did not reproduce the dramatic biological separation implied by the monoclonal DBP measurement.
This result has implications beyond one assay. If a calculated free value is built from a method-sensitive DBP concentration, the apparent free-vitamin difference can inherit that bias. A numerical estimate can therefore look physiologically precise while carrying uncertainty from the analytical inputs beneath it.
Free 25(OH)D has not shown universal superiority for physiological outcomes
If free 25(OH)D were a universally superior indicator of vitamin D biology, it should consistently outperform total 25(OH)D across relevant physiological outcomes. The evidence does not show that pattern.
Aloia and colleagues examined directly measured free 25(OH)D in relation to calcium absorption, parathyroid hormone and markers of bone turnover. Free 25(OH)D was biologically informative, but the evidence did not establish a simple universal threshold or demonstrate that it should replace total 25(OH)D for routine interpretation.
The broader evidence base contains the same caution. In ordinary populations, free and total values frequently track together. In mortality research, systematic review and meta-analysis have not demonstrated a clear general advantage of free or bioavailable 25(OH)D over total 25(OH)D. These findings do not make free vitamin D irrelevant. They constrain the stronger claim that it is universally the better clinical marker.
Measurement capability is ahead of universal clinical standardisation
Modern laboratories can measure free 25(OH)D, and analytical development continues. That is not the same as having one universally standardised clinical interpretation framework.
The IFCC position literature emphasises that vitamin D metabolite and DBP measurements need careful analytical characterisation. More recent work on directly measured free 25(OH)D likewise highlights harmonisation challenges. Sempos and colleagues showed that directly measured free 25(OH)D assays can be compared and harmonised more rigorously, but the field does not yet possess the depth of standardisation and outcome-linked decision thresholds available for conventional total 25(OH)D.
Recent analytical reviews also describe the emerging role of mass spectrometry for free vitamin D measurement. These technologies may improve analytical specificity, but improved measurement alone cannot create clinically validated thresholds. Analytical validity and clinical utility are separate questions.
Free versus total is different from 25(OH)D versus 1,25-dihydroxyvitamin D
The binding question can easily become confused with a different testing question. Free versus total 25(OH)D compares fractions of the same principal vitamin D status metabolite. Measuring 25(OH)D versus 1,25-dihydroxyvitamin D compares different metabolites with different regulatory roles.
A free 25(OH)D assay therefore does not become a substitute for understanding when 25(OH)D or 1,25-dihydroxyvitamin D is the appropriate metabolite to measure. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D addresses that separate distinction.
What total 25(OH)D still tells us well
Total 25(OH)D remains the conventional status marker because it has extensive clinical experience, established standardisation infrastructure and a large evidence base. In people without major disturbances of DBP or albumin, it usually tracks directly measured free 25(OH)D closely enough that the existence of a free fraction does not by itself create a reason to abandon total measurement.
Its limitation is interpretive rather than existential. Total 25(OH)D measures the whole circulating reservoir, and the size of that reservoir is influenced by the proteins carrying it. It is therefore not a direct measurement of receptor activity, intracellular vitamin D metabolism or tissue response. That broader distinction is also central to Vitamin D Status vs Vitamin D Effect.
What free 25(OH)D can add
Free 25(OH)D adds a different view of the circulating system. Its value becomes conceptually strongest when the binding environment is unusual enough that total concentration may no longer map onto the free fraction in the ordinary way.
That makes altered DBP and albumin states scientifically important. Cirrhosis, pregnancy and rare DBP abnormalities demonstrate that the free-to-total relationship is conditional. They support the proposition that free measurement can add information in selected circumstances.
They do not establish universal superiority. The locked evidence does not support replacing total 25(OH)D with free 25(OH)D for routine testing, does not establish a universal free-vitamin target, and does not establish that a free blood concentration directly measures tissue vitamin D sufficiency.
Why the strongest interpretation is conditional rather than competitive
The combined evidence resolves an apparent contradiction. The physiology shows that free and total vitamin D are genuinely different quantities. Population and intervention studies show that they often behave similarly. Altered-binding states show that they can diverge. Analytical studies show that some apparent divergence can also be created or exaggerated by measurement method. Outcome studies fail to establish universal clinical superiority for the free fraction.
These findings fit together rather than cancel one another. Total 25(OH)D is strongly influenced by the circulating carrier reservoir, but that reservoir is a real component of vitamin D physiology rather than analytical noise. Free 25(OH)D is a real unbound compartment, but being free does not prove that it alone determines tissue access or biological effect.
The appropriate interpretation therefore depends on the question. For routine assessment in ordinary binding states, total 25(OH)D retains major practical and evidential advantages. When DBP or albumin is markedly abnormal, understanding the free fraction may help explain why a total result looks discordant with the wider physiological picture. In either case, the analytical method remains part of the meaning of the measurement.
The integrated model
The most defensible model is a transport-and-measurement model rather than a contest between markers. Vitamin D enters a circulating system dominated by DBP binding. Albumin contributes a weaker bound compartment, and a small unbound fraction remains free. Carrier abundance and affinity help determine the size and distribution of that pool. Selected tissues can retrieve protein-bound substrate, so free diffusion is not the only route to cellular access.
In ordinary physiology, total and free 25(OH)D often track closely. When the binding environment changes, the relationship can separate. When measurement of DBP or free vitamin D is method-sensitive, analytical differences can further alter the apparent relationship. The final laboratory number must therefore be interpreted as the output of both physiology and measurement.
This integrated interpretation preserves the value of both markers without granting either one claims the evidence does not support. Total 25(OH)D remains a useful measurement of the circulating vitamin D reservoir. Free 25(OH)D provides a distinct view of the unbound compartment. Neither is a direct readout of all downstream tissue action, and neither can be interpreted responsibly without understanding the transport and analytical system that produced it.
Primary evidence and scientific guidance
Henderson CM, Fink SL, Bassyouni H, et al. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. N Engl J Med. 2019.
Sollid ST, Hutchinson MYS, Berg V, et al. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol. 2016;174:445-452. DOI: 10.1530/EJE-15-1089.
Nielson CM, Jones KS, Chun RF, et al. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. J Clin Endocrinol Metab. 2016;101(5):2226-2234. PMID: 27007693. DOI: 10.1210/jc.2016-1104.
Schwartz JB, Lai J, Lizaola B, et al. A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations. J Clin Endocrinol Metab. 2014;99(5):1631-1637. PMID: 24483159. DOI: 10.1210/jc.2013-3874.
Schwartz JB, Gallagher JC, Jorde R, et al. Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations. J Clin Endocrinol Metab. 2018;103(9):3278-3288. PMID: 29955795. DOI: 10.1210/jc.2018-00295.
Aloia J, Dhaliwal R, Mikhail M, et al. Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover. J Clin Endocrinol Metab. 2015. DOI: 10.1210/jc.2015-2548.
Sempos CT, Lindhout E, Heureux N, et al. Towards harmonization of directly measured free 25-hydroxyvitamin D using an enzyme-linked immunosorbent assay. Anal Bioanal Chem. 2022.
Zhu A, Kuznia S, Boakye D, Schöttker B, Brenner H. Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis. Nutrients. 2022. DOI: 10.3390/nu14193894.
Makris K, Bhattoa HP, Cavalier E, et al. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein: A position paper from the IFCC Committee on bone metabolism. Clin Chim Acta. 2021.
Alexandridou A, Stokes CS, Volmer DA. Measurement of Serum Free Vitamin D Concentrations: Importance, Challenges, and the Emerging Role of Mass Spectrometry. Clin Chem. 2025;71(2):254.
Related reading
Total and Free 25-Hydroxy-Vitamin D and Bacterial Vaginosis in Pregnant African American Women
We compared total and free 25(OH)D concentrations for women according to Nugent score category (normal flora, intermediate flora, and BV) and assessed the odds of BV according to measures of vitamin D status.
Original paper ↗Read more →Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Original paper ↗Read more →Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites
The free 1,25(OH)2D DR was attenuated compared to that of total 1,25(OH)2D.
Original paper ↗Read more →Polymorphisms of the Vitamin D Binding Protein (VDBP) and Free Vitamin D in Patients with Cystic Fibrosis
Objectives/Background: Vitamin D-binding protein (VDBP) and free vitamin D are new markers that are being studied as a possible markers of vitamin D status.
Original paper ↗Read more →Deconvoluting the Biological Roles of Vitamin D-Binding Protein During Pregnancy: A Both Clinical and Theoretical Challenge
The teleological purpose of an ongoing pregnancy is to fulfill its fundamental role of a successful, uncomplicated delivery, in conjunction with an optimal intrauterine environment for the developing fetus.
Original paper ↗Read more →Influence of vitamin D binding protein polymorphism, demographics and lifestyle factors on vitamin D status of healthy Malaysian pregnant women
Therefore, this cross-sectional study aimed to assess the association between GC gene polymorphism, demographics and lifestyle factors with VDD among Malaysian pregnant women.
Original paper ↗Read more →Potential roles of vitamin D binding protein in attenuating liver injury in sepsis
The current study examined the relationship between serum VDBP level and liver injury in sepsis patients, as well as in a mouse model for sepsis and in cultured liver epithelial cell line exposed to lipopolysaccharide (LPS).
Original paper ↗Read more →The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases
Vitamin D (calciferol) is a fat-soluble vitamin that has a significant role in phospho-calcium metabolism, maintaining normal calcium levels and bone health development.
Original paper ↗Read more →Vitamin D-Binding Protein in Pregnancy and Reproductive Health
Improved methods for measuring VDBP and an increased understanding of its role in biological processes have led to a number of newly published studies exploring VDBP in the context of pregnancy.
Original paper ↗Read more →The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes
Vitamin D is important for bone health, but may also have extra-skeletal effects.
Original paper ↗Read more →Vitamin D Binding Protein Gene Polymorphisms (rs4588 and rs7041) and VDBP Levels in Total Hip Replacement Outcomes
This study aimed to analyze the association between these SNPs, serum levels of VDBP and 25(OH)D, and their potential roles in THR outcomes.
Original paper ↗Read more →Vitamin D Binding Protein Structure and Transport Role: Evidence Synthesis
Explore how vitamin D binding protein carries vitamin D metabolites, maintains circulating stores and supports specialised uptake pathways in the body.
Read more →25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy
To evaluate vitamin D binding protein and free 25-hydroxyvitamin D [25(OH)D] levels in healthy controls compared to primary hyperparathyroidism (PHPT) patients, and to examine PHPT before and after surgery.
Original paper ↗Read more →Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation
We aimed to investigate the changes of total 25(OH)D, 25(OH)D3 and 25(OH)D2 in a Thai cohort, according to type of vitamin D supplement (vitamin D3 or D2) and DBP genotype, after receiving vitamin D3 or D2 for 3 months.
Original paper ↗Read more →Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein
Serum 25-hydroxyvitamin D [25(OH)D] is often deficient (.
Original paper ↗Read more →Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study
All participants were genotyped for polymorphisms rs2282679, rs4588, and rs7041.
Original paper ↗Read more →Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry
Our aim was to assess the combined effect of maternal and neonatal VDBP polymorphism heterogeneity in conjunction with different maternal and neonatal 25(OH)D cutoffs on the neonatal anthropometric profile at birth.
Original paper ↗Read more →The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population
Compared with VDI, VDS, or both, VDD showed higher plasma concentrations of fasting blood glucose, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides in males (P 0.05).
Original paper ↗Read more →Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland
We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7−19 yr.
Original paper ↗Read more →Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions
The aim of this review is to assess DBP concentration in different physiological and pathophysiological conditions.
Original paper ↗Read more →Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis
Blacks have different dominant polymorphisms in the vitamin D-binding protein (DBP) gene that result in higher bioavailable vitamin D than whites.
Original paper ↗Read more →Original sources
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene
Henderson CM, Fink SL, Bassyouni H, et al.
Publication details
Henderson CM, Fink SL, Bassyouni H, et al. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. N Engl J Med. 2019.
Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
Published in Eur J Endocrinol (2016).
Publication details
Sollid ST, Hutchinson MYS, Berg V, et al. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol. 2016;174:445-452. DOI: 10.1530/EJE-15-1089.
Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations
Published in J Clin Endocrinol Metab (2016).
Publication details
Nielson CM, Jones KS, Chun RF, et al. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. J Clin Endocrinol Metab. 2016;101(5):2226-2234. PMID: 27007693. DOI: 10.1210/jc.2016-1104.
A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations
Published in J Clin Endocrinol Metab (2014).
Publication details
Schwartz JB, Lai J, Lizaola B, et al. A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations. J Clin Endocrinol Metab. 2014;99(5):1631-1637. PMID: 24483159. DOI: 10.1210/jc.2013-3874.
Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations
Published in J Clin Endocrinol Metab (2018).
Publication details
Schwartz JB, Gallagher JC, Jorde R, et al. Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations. J Clin Endocrinol Metab. 2018;103(9):3278-3288. PMID: 29955795. DOI: 10.1210/jc.2018-00295.
Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover
Published in J Clin Endocrinol Metab (2015).
Publication details
Aloia J, Dhaliwal R, Mikhail M, et al. Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover. J Clin Endocrinol Metab. 2015. DOI: 10.1210/jc.2015-2548.
Towards harmonization of directly measured free 25-hydroxyvitamin D using an enzyme-linked immunosorbent assay
The availability of a new enzyme-linked immunosorbent assay (ELISA) for the determination of free 25(OH)D provides a method for direct measurement of the low levels of non-protein bound 25(OH)D.
Publication details
Sempos CT, Lindhout E, Heureux N, et al. Towards harmonization of directly measured free 25-hydroxyvitamin D using an enzyme-linked immunosorbent assay. Anal Bioanal Chem. 2022.
Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Publication details
Zhu A, Kuznia S, Boakye D, Schöttker B, Brenner H. Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis. Nutrients. 2022. DOI: 10.3390/nu14193894.
Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein – A position paper from the IFCC Committee on bone metabolism
Makris K, Bhattoa HP, Cavalier E, et al.
Publication details
Makris K, Bhattoa HP, Cavalier E, et al. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein: A position paper from the IFCC Committee on bone metabolism. Clin Chim Acta. 2021.
Measurement of Serum Free Vitamin D Concentrations: Importance, Challenges, and the Emerging Role of Mass Spectrometry
Published in Clin Chem (2025).
Publication details
Alexandridou A, Stokes CS, Volmer DA. Measurement of Serum Free Vitamin D Concentrations: Importance, Challenges, and the Emerging Role of Mass Spectrometry. Clin Chem. 2025;71(2):254.